Level Eight Ventures

Level Eight Ventures, founded in 2018 and based in Ann Arbor, Michigan, is a venture capital firm that focuses on investing in innovative companies operating in sectors such as artificial intelligence, clean energy, mobility, healthcare, materials, chemicals, sensors, inspection, resources, and the environment. Recognizing the rapid advancements in biochemistry, materials science, robotics, and artificial intelligence, the firm aims to support outstanding teams that are creating cleaner, smarter, and more sustainable solutions. By providing both time and capital, Level Eight Ventures seeks to drive disruption and foster the development of technologies that will enhance various industries across North America and Europe.

Seamus Hatch

Partner

Daniel Krausz

Partner

Richard Philpott

Partner

3 past transactions

SpinTech MRI

Series A in 2022
SpinTech MRI is a developer of an advanced MRI imaging software platform designed to significantly reduce the time required for brain imaging while enhancing the visualization and automatic detection of critical biomarkers for neurological conditions. These conditions include traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and stroke, which often go undetected with existing methods. By transforming advanced research techniques into practical clinical applications, SpinTech MRI's platform integrates seamlessly with virtually any MRI machine to provide standardized, high-quality images and quantitative biomarkers. This innovative approach aids clinicians in detecting microbleeds and quantifying neuromelanin content, ultimately improving patient outcomes and maximizing the return on investment for expensive imaging equipment. The team comprises physicists, engineers, and entrepreneurs dedicated to advancing imaging technology for patients suffering from neurological diseases.

Pathware

Series A in 2022
Pathware Inc. is a technology company focused on revolutionizing healthcare through its automated point-of-care biopsy assessment system. The company’s flagship product, Bioptic, empowers clinicians and technicians to diagnose pathogens effectively, enhancing the accuracy and speed of disease diagnosis. Pathware also develops a sample management platform that streamlines pathology workflows, minimizes redundancies, and eliminates the need to send samples to central laboratories. This digital pathology platform features innovative hardware and software tools, including AI-powered image analysis and telepathology capabilities, which allow clinicians to scan, visualize, and analyze tissue samples directly in their clinics. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware aims to improve patient care and save lives by facilitating earlier and more precise diagnoses and treatments.

Invision AI

Seed Round in 2017
Invision AI is focused on transforming the Internet of Things into the Internet of Intelligent Things by developing advanced AI software that operates directly on edge devices. This approach allows for the creation of valuable situational insights without the need for expensive hardware or reliance on cloud uploads. The company has created a cloud-based video analytics platform that enhances the functionality of video monitoring technologies. By employing proprietary machine learning algorithms, Invision AI’s platform learns from existing visual data and leverages extensive datasets, which enables professionals to reduce bandwidth costs associated with traditional motion detection systems while significantly improving the user experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.